A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province
Study Details
Study Description
Brief Summary
To observe and evaluate the safety and effectiveness of herombopag in the treatment of thrombocytopenia-related diseases in Henan Province
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Detailed Description
This study is designed as a real-world study on the treatment of thrombocytopenia-related diseases with Herombopag, to observe and analyze the safety and efficacy of Herombopag for thrombocytopenia-related diseases in the real world.
Study Design
Outcome Measures
Primary Outcome Measures
- Incidence of adverse events after the treatment of Herombopag [From the treatment of Herombopag to 28 days after the end of the medication]
The investigator will observe incidence of adverse events after the treatment of Herombopag, including thrombosis, diarrhea, abnormal liver function and so on.
Secondary Outcome Measures
- Changes of the platelet counts after the treatment of Herombopag [From the treatment of Herombopag to 28 days after the end of the medication]
The investigator will assess the changes of the platelet counts after the treatment of Herombopag。
- Proportion of patients with platelet transfusion [From the treatment of Herombopag to 28 days after the end of the medication]
The investigator will assess the proportion of patients with platelet transfusion after the treatment of Herombopag。
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Thrombocytopenia related diseases;
-
Volunteer to join this study and sign an informed consent form;
-
Clinical evaluation can benefit from Herombopag.
Exclusion Criteria:
-
Those who have been confirmed to be allergic to Herombopag and/or its excipients;
-
Pregnant or breastfeeding women;
-
Except for patients with contraindications to Herombopag;
-
Doctors evaluate patients who are not suitable for inclusion.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Henan Cancer Hospital | Zhengzhou | Henan | China | 450008 |
Sponsors and Collaborators
- SuxiaLuo
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HNHQRWS